Live Breaking News & Updates on பயோடெக் மற்றும் பார்மா|Page 8
Stay updated with breaking news from பயோடெக் மற்றும் பார்மா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna. Getting the shots distributed is turning into a feat, too. Managing that distribution for the government’s Operation Warp Speed program is McKesson (ticker: MCK), and its role has helped lift its stock 22% this year, to $170, compared with the 14% gain of the Morgan Stanley’s Ricky Goldwasser figures that the Moderna (MRNA) shots alone could be worth as much as $1 billion to McKesson’s 2021 revenue and $1 a share to its earnings. In a Thursday note, she updates her forecasts and reiterates her Buy rating on the stock, which she thinks could reach $219. McKesson shares were down 0.1%, at $169.83, in recent trading. The S&P 500 was up 0.1%. ....